. . . . . . . . . "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." . . . . . . "Adults" . . . "2021-08-24T20:13:48.454886"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "iljWTTgn0Ox8H8iO6503RLNN8kfin8Nvtgxq0pv9fMA0hhpOuIkcO3yzbEbyqw2kLCnqJ4OfJ6abw5RJHQXoZujG/PSkOtrrjZb6m4BdxxnFqMz2Ifisvzq0uxcquQRUB0OEGdRPwqeh/UeXP3GxQqq5h8mRZ7RENsCHB/MboQ8=" . . "2021-08-24T20:13:48.454886"^^ . . .